Background: Cervical Spondylotic Myelopathy (CSM) is the predominant cause of spinal cord dysfunction in the elderly, hence, the patients are frail and susceptible to complications. Surgical options include anterior decompression and fusion, posterior stand-alone laminectomy, laminectomy and fusion and laminoplasty. Considering the risk of post-laminectomy kyphosis after stand-alone laminectomy or distal junction kyphosis, pseudarthrosis or implant failure after fusion surgery, the optimal surgical approach is a matter of controversy. The objective of this study is to compare stand-alone laminectomy with laminectomy and fusion to determine which treatment has the lowest frequency of reoperations.Methods: This is a multicenter randomized, controlled, parallel group non-inferiority trial. A total of 300 adult patients are allocated in a ratio of 1:1. The primary endpoint is reoperation for any reason at five years of follow-up. Sample size and power calculation were performed by estimating the reoperation rate after laminectomy to 3.4% and after laminectomy with fusion to 7.9% based on the data from the Swedish spine registry (Swespine) on patients with CSM. Secondary outcomes are the patient derived Japanese orthopaedic association (P-mJOA) score, Neck disability index (NDI), European quality of life five dimensions (EQ-5D), Numeric rating scale (NRS) for neck and arm pain, Hospital anxiety and depression scale (HADS), development of kyphosis measured as the cervical sagittal vertical axis (cSVA) and, death. Clinical and radiological follow-up is performed at 3, 12, 24 and 60 months after surgery. The main inclusion criterium is 1-4 levels of CSM in the subaxial spine, C3-C7. The REDcap software will be used for safe data management. Data will be analyzed according to the per protocol (PP) population, defined as randomized patients who are still alive without having emigrated or left the study after two and five years. Discussion: This will be the first randomized controlled trial comparing two of the most common surgical treatments for CSM; the posterior muscle-preserving selective laminectomy and posterior laminectomy with instrumented fusion. The results of the MyRanC study will provide surgical treatment recommendations for CSM. This may result in improvements in surgical treatment and clinical practice regarding CSM.Trial registration: Clinical trials.gov, identifier NCT04936074, 23rd of June 2021 (https://clinicaltrials.gov/ct2/show/NCT04936074?term=NCT04936074&draw=2&rank=1).